ArticleScientific reports2025
Association between thyroid function and osteopenia or osteoporosis: a cross-sectional study in China.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- The association between periodontitis and hypothyroidism: A comprehensive review.The Journal of international medical research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid dysfunction is associated with bone health, but the relationship with osteopenia remains unclear. This study aimed to investigate the association between thyroid function and osteopenia/osteoporosis across different age groups. The study included 4508 men and 1438 women who underwent health check-ups between January 2021 and December 2023. Bone mineral density (BMD) was measured using dual energy X-ray absorptiometry. Logistic regression analysis was employed to evaluate the association between thyroid function and the risk of osteopenia/osteoporosis. The results showed that in postmenopausal women, both hyperthyroidism and age increased the risk of osteopenia and osteoporosis, while body mass index (BMI) was negatively correlated with both conditions. In men over 50, hyperthyroidism and age were also linked to a higher risk of osteoporosis. Among postmenopausal women, higher thyroid-stimulating hormone (TSH) levels were negatively associated with osteopenia risk. In men aged 50 and above, free thyroxine (fT4) levels were inversely related to osteopenia and osteoporosis risk. In men under 50, fT4 levels were negatively linked to the risk of low bone mass. These findings suggest that TSH and fT4 levels may influence bone health, with these effects varying by age and sex. Further studies are needed to confirm these findings and explore potential mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.